CARsgen Therapeutics Holdings Limited

CARsgen Therapeutics Holdings Limited - Enterprise Valueverified

2171.HK

Price:

$11.82

Market Cap:

$5.74B

CARsgen Therapeutics Holdings Limited, a biopharmaceutical firm founded in Shanghai, China, in 2014, focuses on the discovery, development, and commercialization of advanced chimeric antigen receptor T (CAR-T) cell therapies. The company's efforts are directed toward treating various hematological malignancies and solid tumors across China and the United States. Its robust pipeline includes several key candidates: CT053, an autologous CAR-T product, is currently in a pivotal Phase II trial in China for relapsed/refractory multiple myeloma. Additionally, CT041, another autologous CAR-T, is undergoing Phase Ib/II clinical trials for advanced gastric/gastroesophageal junction and pancreatic can...[Read more]

Industry

Biotechnology

IPO Date

2021-06-18

Stock Exchange

HKSE

Ticker

2171.HK

The Enterprise Value as of October 2026 (TTM) for CARsgen Therapeutics Holdings Limited (2171.HK) is 4.41B

According to CARsgen Therapeutics Holdings Limited’s latest financial reports and current stock price. The company's current Enterprise Value is 4.41B. This represents a change of -31.50% compared to the average of 6.44B of the last 4 quarters.

CARsgen Therapeutics Holdings Limited (2171.HK) Historical Enterprise Value (quarterly & annually)

How has 2171.HK Enterprise Value performed in the past?

The mean historical Enterprise Value of CARsgen Therapeutics Holdings Limited over the last ten years is 4.84B. The current 4.41B Enterprise Value has changed 9.02% with respect to the historical average. Over the past ten years (40 quarters), 2171.HK's Enterprise Value was at its highest in in the December 2021 quarter at 11.97B. The Enterprise Value was at its lowest in in the June 2024 quarter at 1.03B.

Quarterly (TTM)
Annual

Average

4.84B

Median

4.06B

Minimum

1.40B

Maximum

11.96B

CARsgen Therapeutics Holdings Limited (2171.HK) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of CARsgen Therapeutics Holdings Limited Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Maximum Annual Increase = 194.77%

Maximum Annual Enterprise Value = 11.96B

Minimum Annual Increase = -72.80%

Minimum Annual Enterprise Value = 1.40B

Quarterly (TTM)
Annual
YearEnterprise ValueChange
20256.30B81.59%
20243.47B147.84%
20231.40B-72.80%
20225.15B-56.96%
202111.96B194.77%
20204.06B169.06%

CARsgen Therapeutics Holdings Limited (2171.HK) Average Enterprise Value

How has 2171.HK Enterprise Value performed in the past?

The current Enterprise Value of CARsgen Therapeutics Holdings Limited (2171.HK) is greater than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

3-year avg

3.72B

5-year avg

5.66B

10-year avg

4.84B

CARsgen Therapeutics Holdings Limited (2171.HK) Enterprise Value vs. Peers

How is 2171.HK’s Enterprise Value compared to its peers?

CARsgen Therapeutics Holdings Limited’s Enterprise Value is greater than JW (Cayman) Therapeutics Co. Ltd (823.25M), greater than Immunotech Biopharm Ltd (538.74M),

CompanyEnterprise ValueMarket cap
823.25M$1.13B
538.74M$237.74M

Build a custom stock screener for CARsgen Therapeutics Holdings Limited (2171.HK) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like CARsgen Therapeutics Holdings Limited using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Custom stock screener in Wisesheets

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

CARsgen Therapeutics Holdings Limited (2171.HK) and other stocks custom spreadsheet templates

The easiest way to analyze a company like CARsgen Therapeutics Holdings Limited or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Custom stock templates in Wisesheets

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.

Frequently asked questions❓

What is the Enterprise Value?

How can you use the Enterprise Value?

What is CARsgen Therapeutics Holdings Limited's Enterprise Value?

What is the highest Enterprise Value for CARsgen Therapeutics Holdings Limited (2171.HK)?

What is the 3-year average Enterprise Value for CARsgen Therapeutics Holdings Limited (2171.HK)?

What is the 5-year average Enterprise Value for CARsgen Therapeutics Holdings Limited (2171.HK)?

How does the current Enterprise Value for CARsgen Therapeutics Holdings Limited (2171.HK) compare to its historical average?